Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof
This invention relates to extended release injectable formulations for combating parasites in animals, comprising 5 to 20% (w/w) isoxazoline active agent of Formula (IIa), 1 to 30% (w/w) of a pharmaceutically acceptable polymer, and 40 to 85% (w/w) of a solvent. This invention also provides for impr...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | This invention relates to extended release injectable formulations for combating parasites in animals, comprising 5 to 20% (w/w) isoxazoline active agent of Formula (IIa), 1 to 30% (w/w) of a pharmaceutically acceptable polymer, and 40 to 85% (w/w) of a solvent. This invention also provides for improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the extended release injectable formulations of the invention to the animal in need thereof. |
---|